Prevention of intra-abdominal abscesses and adhesions using a hyaluronic acid solution in a rat peritonitis model

Arch Surg. 1999 Sep;134(9):997-1001. doi: 10.1001/archsurg.134.9.997.

Abstract

Hypothesis: Hyaluronic acid (HA)-based bioresorbable membrane and 0.4% HA solution reduce intraabdominal adhesion and abscess formation in a rat peritonitis model.

Design: Randomized laboratory experiment.

Setting: A university hospital.

Interventions: In 72 male Wistar rats, a bacterial peritonitis was induced using the cecal ligation and puncture model. Animals were randomized to receive isotonic sodium chloride solution (group 1), HA-carboxymethylcellulose bioresorbable membrane (group 2), or 0.4% HA solution (group 3). Half of each group were killed at day 7 and half at day 21, and adhesions were scored in a blind fashion. The presence and sizes of intra-abdominal abscesses were noted. Cultures were taken for bacterial analysis.

Main outcome measures: Intra-abdominal adhesions and abscesses.

Results: The median severity of adhesions was significantly lower in group 3 compared with group 1 rats at day 7 (II [range, I-IV] vs IV [range, I-IV], respectively; P=.02) and at day 21 (II [range, I-III vs IV [range, II-IV], respectively; P=.02). There was no significant difference between group 2 and group 1 rats on either day. At day 7, abscesses larger than 2 cm were found in 6 of 12 group 1 rats and in 4 of 12 group 2 rats, but in 0 of 11 group 3 rats (P=.01). At day 21, 0 of 11 group 3 rats had an intra-abdominal abscess, in contrast to 4 (33%) of 12 group 1 rats and 5 (45%) of 11 group 2 rats. All cultures of abscesses revealed polymicrobial flora.

Conclusion: Adhesion and abscess formation are reduced using a 0.4% HA solution, and not HA-carboxymethylcellulose bioresorbable membrane, in a rat model of generalized bacterial peritonitis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abdominal Abscess / etiology
  • Abdominal Abscess / prevention & control*
  • Adjuvants, Immunologic / therapeutic use*
  • Animals
  • Disease Models, Animal
  • Hyaluronic Acid / therapeutic use*
  • Male
  • Peritonitis / complications*
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Solutions
  • Tissue Adhesions / etiology
  • Tissue Adhesions / prevention & control

Substances

  • Adjuvants, Immunologic
  • Solutions
  • Hyaluronic Acid